Cardiomyocyte Renewal Lab Gets Spotlight in Circulation
The Cardiomyocyte Renewal team has been prominently featured in this spotlight story from Circulation, “Spotlight on YAP: Unlocking New Insights to...
In The News
Dr. Emerson Perin Leads DREAM-HF Trial – Demonstrating the Life-Saving Potential of Cell Therapy
Dr. Emerson C. Perin, Medical Director at The Texas Heart Institute, has been highlighted as the lead investigator in the...
ReVolutionary Heart Pump Offers New Hope for Infants with Congenital Heart Disease
A dedicated team of researchers and physicians are closer to realizing their hopes of a new device that will change...
Dr. Nikolaos A. Diakos Awarded MacDonald Research Grant for Cardiogenic Shock Study
Dr. Nikolaos A. Diakos of The Texas Heart Institute has been awarded a Roderick D. MacDonald Research Fund grant to...
7 Hills Pharma Announces First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors
The Texas Heart Institute is excited to share the groundbreaking progress of 7 Hills Pharma Inc. (“7 Hills”), a clinical-stage...
Dr. Stephanie Coulter Talks PCOS and Its Surprising Links to Cognitive and Heart Health Risks on KPRC
In a morning segment on KPRC, Haley Hernandez joined THI at the inaugural Cardiometabolic Syndrome Conference to chat with Dr....
Dr. Jennifer Cozart Pioneers First Use of AtriClip FLEX-Mini in Texas, Advancing Heart Surgery Innovation
Another groundbreaking moment in cardiovascular surgery has again unfolded at The Texas Heart Institute. Dr. Jennifer Cozart, a leading cardiovascular...
Dr. Emerson Perin Participates in UofL Clinical Trial for New Investigational Therapy for Heart Failure
The Texas Heart Institute’s Emerson Perin, MD is collaborating with University of Louisville (UofL) on a new investigational stem cell...
Joseph Rogers, MD, named to American Board of Internal Medicine’s Cardiovascular Board
Houston, Texas, July 24, 2024 – The Texas Heart Institute, a globally renowned cardiovascular health center, announced today that Joseph...
News Around the World: BiVACOR Total Artificial Heart Makes History
The Texas Heart Institute, located in the heart of the Texas Medical Center, broadcasted a live press conference from The...
The Texas Heart Institute Implants BiVACOR® Total Artificial Heart
First-in-human novel valveless artificial heart implanted in a patient with end-stage heart failure as a bridge to heart transplant ...
A Discovery by The Texas Heart Institute & 7 Hills Pharma Continues Development under a $4.7 Million CPRIT Grant to Address Cancer Treatment Disparities
Peter Vanderslice, PhD, Senior Investigator and Director, MCRL, Molecular Cardiology Research, was highlighted in a recent announcement from 7 Hills Pharma,...
